Merit Medical Systems (Nasdaq:MMSI) announced today that it executed an asset purchase agreement with EndoGastric Solutions. The agreement features a $105 million total cash consideration for EndoGastric Solutions’ EsophyX Z+ device. EndoGastric Solutions designed its device as a minimally invasive, non-pharmacological treatment for patients with GERD. EsophyX Z+ treats GERD by restoring the body’s reflux […]
EndoGastric Solutions
EndoGastric Solutions launches EsophyX Z+ GERD treatment device
EndoGastric Solutions said this week it launched the EsophyX Z+ device designed for use in transoral incisionless fundoplication procedures to reconstruct the gastroesophageal valve to treat patients with severe gastroesophageal reflux disease. The device is designed to be used with a partial fundoplication technique that secures tissue with dual deployment of SerosaFuse implantable fasteners, the […]
Medicare expands reimbursement for EndoGastric Solutions EsophyX device
EndoGastric Solutions said today that a Center for Medicare & Medicaid Services administrator granted reimbursement coverage for its EsophyX device for treating gastroesophageal reflux. National Government Services extended coverage for transoral incisionless fundoplication using the EsophyX device to some 9.3 million patients in Connecticut, Illinois, Maine, Massachusetts, Minnesota, New Hampshire, New York, Rhode Island, Vermont and Wisconsin effective Dec. […]
